What frankincense does and what the evidence actually supports

Frankincense is a resin from trees in the Boswellia genus, used for thousands of years in traditional medicine and religious practice. The active compounds—mainly boswellic acids—appear to reduce inflammation by blocking signaling molecules your immune system uses to trigger swelling and pain. Most human research shows modest effects on joint pain and inflammatory markers, particularly in people with osteoarthritis or rheumatoid arthritis. The evidence is real but limited: studies are often small, funded by supplement makers, or conducted in countries with less rigorous oversight than U.S. trials.

Frankincense will not replace a prescribed anti-inflammatory medication, and it works slowly—most studies measure effects after 8 to 12 weeks of daily use. What it may do is reduce pain or swelling enough to notice, or work alongside other treatments. The research distinguishes between what happens in a test tube (frankincense blocks inflammatory pathways) and what happens in a person (modest improvement in symptoms). That gap matters.

Key Takeaways

  • Boswellic acids in frankincense resin reduce production of inflammatory molecules in lab and animal studies, but human trials show smaller, more variable effects.
  • The strongest evidence is for joint pain in osteoarthritis and rheumatoid arthritis, with improvements typically appearing after 8 to 12 weeks of daily use.
  • Frankincense appears safe at typical doses, though it can interact with blood thinners and may cause digestive upset in some people.
  • Most human studies are small or funded by manufacturers, so the true effect size remains uncertain and may be smaller than published results suggest.

How boswellic acids reduce inflammation

The mechanism is well-documented in cell and animal research. Boswellic acids—the main active compounds in frankincense resin—inhibit an enzyme called 5-lipoxygenase, which your body uses to produce leukotrienes, signaling molecules that trigger inflammation and immune response. By blocking this pathway, frankincense reduces the chemical signals that tell your immune cells to swarm an area and cause swelling.

In isolated human immune cells grown in the lab, boswellic acids also suppress production of tumor necrosis factor (TNF) and interleukin-6, two cytokines involved in chronic inflammation. Mice and rats given frankincense extract show reduced joint swelling and cartilage damage in models of arthritis. This is solid mechanistic evidence—it explains why frankincense might work—but it does not tell you how much benefit a person will feel.

Joint pain and osteoarthritis: the strongest human evidence

The most consistent human data comes from people with osteoarthritis and rheumatoid arthritis. A 2014 systematic review in Phytotherapy Research identified seven randomized controlled trials in people with knee osteoarthritis. Most showed modest reductions in pain and stiffness, with improvements ranging from 20 to 65 percent depending on the study and how pain was measured. A 2019 trial published in Phytomedicine found that 100 participants taking a standardized Boswellia serrata extract for 90 days reported less knee pain and better function than those on placebo, though the difference was small enough that some participants in both groups improved.

For rheumatoid arthritis, the evidence is thinner. A small 2003 trial in Phytomedicine found that 30 people with active rheumatoid arthritis who took Boswellia serrata extract for 24 weeks had less joint swelling and morning stiffness than those on placebo. The effect was measurable but modest. No large, well-funded trial has replicated this in the United States or Europe, so the finding remains preliminary.

One important caveat: most trials lasted 8 to 12 weeks, and some measured pain on subjective scales (how much pain do you feel?) rather than objective markers like swelling or blood inflammatory markers. This means some of the benefit could reflect placebo effect or natural fluctuation in pain rather than a drug-like action of frankincense.

Other claimed uses and what the research shows

Frankincense is marketed for asthma, inflammatory bowel disease, and general immune support. The evidence for these uses is much weaker. A small 2016 trial found that 60 people with asthma who took Boswellia serrata for 12 weeks had fewer asthma symptoms and better lung function than those on placebo, but the study was conducted in India and published in a journal with limited international visibility. No large U.S. or European trial has confirmed this.

For inflammatory bowel disease (Crohn's disease and ulcerative colitis), one small trial found that Boswellia serrata was as effective as the drug mesalamine in reducing symptoms, but the study was tiny (20 people per group) and not blinded, meaning both participants and researchers knew who was taking what. This design is prone to bias. Larger, blinded trials have not been conducted.

Claims about frankincense improving skin, boosting memory, or fighting cancer rest on cell or animal studies with no human evidence. These are not established uses, and marketing them as such overstates what is known.

How to use frankincense and what form matters

Frankincense comes as a resin (the dried sap, often chewed or dissolved), an essential oil (concentrated volatile compounds, usually inhaled), an extract or capsule (standardized to boswellic acid content), or a cream. The research on joint pain used standardized extracts, usually Boswellia serrata, dosed at 300 to 650 mg per day divided into two or three doses. These extracts are standardized to contain a known percentage of boswellic acids, usually 30 to 65 percent.

Essential oil is not the same as the resin or extract. Essential oils are volatile compounds that evaporate when heated; they do not contain the boswellic acids that appear responsible for anti-inflammatory effects. Inhaling frankincense essential oil may feel calming, but it is not the same as taking an extract by mouth. Topical creams containing frankincense extract may reduce pain in the joint being treated, though the evidence is limited.

If you are considering frankincense, a standardized extract taken by mouth is the form most studied. Typical doses in research are 300 to 650 mg daily, taken with food to reduce stomach upset.

Safety, interactions, and who should avoid it

Frankincense extract is generally well-tolerated at typical doses. The most common side effects are mild digestive complaints—nausea, heartburn, or loose stools—reported in a small percentage of people in trials. Allergic reactions are rare but possible, especially in people sensitive to other plant resins.

Frankincense may interact with blood thinners like warfarin or clopidogrel, since boswellic acids have mild anticoagulant properties. If you take a blood thinner, discuss frankincense with your doctor before starting. Pregnant and nursing people should avoid it, as safety data in these groups does not exist. People with bleeding disorders should also avoid it.

Frankincense is not a substitute for prescribed medications for arthritis, asthma, or inflammatory bowel disease. If you are considering it alongside a current treatment, tell your doctor, particularly if you take blood thinners or immunosuppressants.

Why the evidence is smaller than it appears

Most frankincense trials are small (20 to 100 participants), conducted outside the United States, and funded by supplement manufacturers or universities in countries with less stringent oversight of supplement research. Smaller trials are more likely to show positive results by chance, and manufacturer funding introduces bias—companies are unlikely to publish negative findings. When researchers from independent institutions in the U.S. or Europe conduct large, blinded trials of supplements, the effects often shrink compared to earlier smaller studies.

Publication bias also matters: studies showing frankincense works are more likely to be published and cited than studies showing it does not. This makes the overall evidence look stronger than it is. The honest summary is that frankincense probably reduces joint pain modestly in some people with osteoarthritis, but the true effect size is uncertain and may be smaller than published trials suggest.

Frequently Asked Questions

Can I use frankincense instead of ibuprofen or other pain medication?

No. Frankincense works slowly (8 to 12 weeks) and produces smaller pain reduction than NSAIDs or prescription anti-inflammatories. It may reduce pain enough to notice, but it is not a replacement for prescribed medication. Some people use it alongside other treatments, but discuss this with your doctor first, especially if you take blood thinners.

Is frankincense essential oil the same as the extract?

No. Essential oil contains volatile compounds that evaporate; it does not contain the boswellic acids that appear to reduce inflammation. Inhaling essential oil may feel calming, but it is not the same as taking an extract by mouth. The research on joint pain used oral extracts, not essential oils.

How long does it take to feel a difference?

Most studies measure effects after 8 to 12 weeks of daily use. Some people notice improvement sooner, but if you do not see any change after 12 weeks, frankincense is unlikely to help you. Do not expect when ready relief like you would from ibuprofen.

Is frankincense safe to take long-term?

Limited data exists on use beyond 12 weeks. Short-term use appears safe in most people, with mild digestive upset being the most common side effect. If you plan to use it long-term, discuss it with your doctor, especially if you take blood thinners or have a bleeding disorder.

What does "standardized to boswellic acids" mean?

It means the extract has been tested and adjusted so that each dose contains a known percentage of boswellic acids, usually 30 to 65 percent. This matters because the boswellic acids are the compounds shown to reduce inflammation. Non-standardized products may contain little or none, making them unlikely to work.